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     INTRODUCTION 
  Dengue is a mosquito-borne acute systemic viral infection 
caused by any one of four serotypes of dengue virus (DENV). 
The ongoing dengue pandemic represents a major challenge 
to health systems in developing countries. Recent estimates of 
the disease burden suggest transmission occurs in up to 124 
countries, with at least 35 million symptomatic cases per year 
and around 20,000 deaths.  1   There are no licensed vaccines 
or anti-viral therapies for prevention or treatment, although 
these are in development.  2,  3  
  In Vietnam, dengue hemorrhagic fever was first identified 
in 1963 in the Mekong Delta region of southern Vietnam.  4  
Between 1963 and 1995, Vietnam reported 1,518,808 den-
gue hemorrhagic fever cases and 14,133 deaths.  5   Data from 
the dengue surveillance program in southern Vietnam show 
epidemic peaks of increasing magnitude occurring approxi-
mately every 5 years between 1975 and 1987, with a longer 
gap of 11 years preceding a large epidemic of 119,429 den-
gue hemorrhagic fever (DHF) cases and 342 fatalities in 1998.  6  
It is not known whether age-related trends in dengue inci-
dence in Vietnam are following a similar pattern to Thailand, 
where a striking increase in the average age of dengue cases 
has been observed.  7   Furthermore, risk factors for severe and 
fatal dengue among hospitalized patients have not previously 
been described for Vietnam nor have they been documented 
extensively elsewhere. A better understanding of populations 
at high risk of complications and poor outcomes in endemic 
settings can inform the future implementation of dengue vac-
cines and anti-viral drugs. 
  The Hospital for Tropical Diseases (HTD) is the tertiary 
center for infectious diseases in Ho Chi Minh City (HCMC). 
Children’s Hospitals Number 1 and Number 2 (CH1 and 
CH2) are the two main pediatric hospitals in HCMC. The aims 
of the current study were to characterize trends in the clinical 
and epidemiological characteristics of dengue cases admitted 
to these hospitals, to identify epidemiological risk factors for 
severe disease and death, and to discuss the implications of 
these observations for future clinical management, vaccines, 
and therapeutics. 
   MATERIALS AND  METHODS 
    Dengue patient and population data.     Data were obtained 
from the central hospital records of the HTD, CH1, and CH2 
in Ho Chi Minh City, Vietnam, on the number of clinically 
diagnosed dengue cases admitted between 1996 and 2009. 
Anonymous addresses at the district level were also obtained 
from hospital records of dengue patients admitted in 2008 and 
2009. Population data were obtained from the Ho Chi Minh 
City statistical office website.  8  
   Case  definitions.     Dengue cases were diagnosed based on 
clinical signs, symptoms, and hematological tests and classified 
by severity grade according to the Vietnam Ministry of Health 
guidelines, which are adapted from the 1997 World Health 
Organization (WHO) guidelines.  9   A discharge diagnosis was 
recorded for each patient according to the International 
Classification of Diseases, revision 10 (ICD-10). Only patients 
with a clinical diagnosis of dengue were included in the dataset 
for this study, but the coding applied to these patients varied 
slightly between the study hospitals. Dengue patients at HTD 
included those with an ICD-10 code for dengue fever (DF) 
or DHF at discharge. All clinically diagnosed dengue cases at 
CH1 received an ICD-10 code for DHF, whereas at CH2, all 
patients with a clinical diagnosis of dengue received an ICD-10 
code for viral hemorrhagic fever. Modified ICD codes were 
recorded at discharge by the hospitals to distinguish between 
DHF severity grades, with DHF grades 3 and 4 classified as 
dengue shock syndrome (DSS). 
   Diagnostic  serology.     Since 2004, the HTD has used two 
formats of an immunoglobulin M (IgM) antigen capture 
ELISA for the presumptive laboratory diagnosis of dengue 
in a proportion of clinically suspected cases. During 2004 and 
2005, cases were tested using a commercially available DENV 
IgM antigen-capture (MAC) enzyme-linked immunosorbent 
assay (ELISA; Inverness Medical, Brisbane, Australia). From 
2006, an in-house MAC ELISA using reagents from Venture 
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Technologies (Sarawak, Malaysia) has been used. The results 
of the diagnostic serology, where performed, were not linked 
to the central patient records; therefore, the laboratory data 
were analyzed separately from the main patient dataset. 
   DENV  serotype  prevalence.     Since 1999, acute blood 
specimens have been collected from a subset of adult and 
pediatric dengue patients admitted to HTD and enrolled in 
various prospective clinical studies. These specimens were 
analyzed by reverse transcription polymerase chain reaction 
(RT-PCR), as described previously,  10   for the determination of 
the infecting DENV serotype. These data have been published 
elsewhere  11   and are reproduced as a supporting file to this 
manuscript. 
   Dengue  incidence  data.     The Pasteur Institute of Ho Chi 
Minh City collates surveillance data on the number of dengue 
cases admitted to hospitals in the southern 20 provinces of 
Vietnam and produces annual estimates of the incidence of 
dengue per 100,000 population in southern Vietnam. These 
data have been published elsewhere  11  and are reproduced with 
the permission of the Pasteur Institute HCMC for the purpose 
of comparison with the results of the current study. 
   Data  analysis.     All analyses were performed in SPSS for 
Windows version 14 (IBM, Somers, NY) and Stata/IC version 
11 (Stata Corp., College Station, TX). χ  2   test statistics were 
calculated for comparisons of proportions between groups. A 
non-parametric test of the equality of medians was used for 
comparisons of non-normally distributed continuous variables 
between groups. The relationship between two continuous 
variables was analyzed by linear regression. Logistic regression 
was used to model the association between patient characteristics 
and the occurrence of DSS or mortality. Variables that were 
significant at the < 0.05 level in univariate analysis were included 
in a multivariate logistic regression model. Two-sided   P   values 
< 0.01 were considered statistically significant in the multi-
variate model. Missing values were imputed in the multivariate 
model using Stata’s mi impute command with the logistic 
regression method for binary variables. MapInfo geographical 
information software version 9 (Pitney Bowes Software Inc., 
Troy, NY) was used for geographic mapping of dengue cases. 
    RESULTS 
    Case burden of dengue at three referral hospitals in HCMC.  
  Between 1996 and 2009, dengue was clinically diagnosed in 
132,480 patients admitted to one of the three study hospitals 
(56,965 at HTD, 45,275 at CH1, and 30,240 at CH2). The 
annual caseload of dengue at the three hospitals peaked at 
10,579 in 1998 and again, in 2008, at 22,860 admissions after 
increasing steadily over the previous decade (  Figure 1A  ). The 
trend in case load at the three study hospitals closely reflected 
the incidence of hospitalized dengue in southern Vietnam 
as reported by the Ministry of Health dengue surveillance 
program (  Figure 1B  ). 
    A DENV-IgM laboratory test was performed in 29.7% 
(annual range = 11.1–41.0%) of clinically diagnosed dengue 
cases at HTD between 2004 and 2009. Of those tested, 71.7% 
(annual range = 63.8–75.5%) were serologically positive for 
DENV-IgM in a single specimen (  Table 1  ). The proportion of 
tested patients with a positive IgM test result was higher if the 
specimen was collected ≥ 5 days after onset of illness (  Table 1  ). 
      The  relative  prevalence  of  the  four  dengue  virus  serotypes 
among dengue patients admitted to HTD fluctuated over time, 
with periodic replacement of the dominant serotype approxi-
mately every 3 years (  Supplemental Figure 1  ). DENV-1 has 
accounted for the vast majority of infections during the excep-
tionally high case burden years between 2007 and 2009.    
 Trends in the age distribution of dengue patients.   All dengue 
patients at CH1 and CH2 were children aged ≤ 15 years. Adults 
represented an increasing proportion of the dengue patient 
population at HTD over time (  Figure 1A  ), from 18% in 1996 
to 66% in 2009. Data on the precise age of dengue cases were 
available since 2000 at CH1 and CH2 and since 2001 at HTD. 
The median age of pediatric dengue patients admitted to the 
three study hospitals declined from 10 years of age in 2002–
2004 to 8 years of age in 2007–2009 (  Figure 2A  ) (estimated 
change in median age of pediatric patients per year from 2002 
to 2009 = −0.36 years, 95% confidence interval [CI] = −0.48 
to −0.23 years). The age distribution of pediatric cases in 2000 
was similar to that seen in 2007–2009. In contrast, the median 
age of adult dengue patients admitted to HTD has increased 
steadily over the past decade, from 20 years in 2001 to 23 years 
in 2009 (  Figure 2B  ) (estimated change in median age of adult 
patients per year from 2001 to 2009 = 0.30 years, 95% CI = 
0.11–0.49 years). 
        Gender bias in the dengue case burden.    Fifty-seven  percent 
of the pediatric dengue patients admitted to the three study 
hospitals between 1996 and 2009 were male, and this gender 
bias was observed each year at each of the hospitals ( Figure 3A ). 
Among adult dengue patients admitted to HTD during the 
  Figure   1.        Temporal trends in dengue admissions in Ho Chi Minh 
City, Vietnam, from 1996 to 2008. (  A  ) Bars show the number of in-
patients with clinically diagnosed dengue each year at each of the 
three study hospitals. Lines show the number of dengue cases in chil-
dren aged 15 years or less (triangles) and adults over the age of 15 
(circles) combined across the study sites. (  B  ) Shown for comparison 
is the annual incidence of hospitalized dengue per 100,000 people in 
the southern 20 provinces of Vietnam derived from cases reported 
through the southern Vietnam dengue surveillance system. Data col-
lated by and reproduced with permission from the Pasteur Institute 
HCMC. This figure appears in color at   www.ajtmh.org  .       129 DENGUE IN VIETNAM
study period, 54% were male. Among pediatric patients with 
DSS, the gender bias was somewhat reduced but still apparent 
(55% overall; annual range = 50–61%) (  Figure 3B  ). 
    To determine whether this predominance of males was spe-
cific to dengue patients, we obtained data on the sex distri-
bution of all admissions to CH1 and CH2 from 2000 to 2008. 
The gender bias to males was even more pronounced for total 
admissions than for dengue (  Figure 3C  ). Of almost 1 mil-
lion admissions at the two pediatric hospitals between 2000 
and 2008, 63% (594,293 of 941,888) were male. This bias was 
observed consistently each year and at both hospitals, with 
a minimum proportion of males of 59% at CH2 in 2002 and 
a maximum of 75% at CH1 in 2004 (  Figure 3C  ). The bias to 
males was particularly marked in 2003–2006. 
      DSS and case fatality rate.     DSS is a pathognomonic and 
severe life-threatening complication of dengue. A total of 
14,079 DSS patients were diagnosed at HTD, CH1, and CH2 
between 1996 and 2009. These figures exclude any DSS cases 
at CH2 between 1996 and 1999, because data on disease 
severity were not available. The vast majority (96.6%) of all 
  Figure   2.        Age distribution of hospitalized dengue cases. (  A )  Circles 
show the median and lines show the interquartile range of the age of 
pediatric dengue patients admitted to Children’s Hospitals 1 and 2 
(CH1 and CH2) and the Hospital for Tropical Disease (HTD) each 
year from 2000 to 2009. In 2000, there was no data from HTD. The 
solid line indicates the total number of pediatric admissions for den-
gue (≤ 15 years) across the three hospitals each year. (  B  ) Circles show 
the median and lines show the interquartile range of the age of adult 
dengue patients admitted to HTD each year from 2001 to 2009. The 
solid line indicates the total number of adult admissions for dengue 
(> 15 years) at HTD each year. This figure appears in color at   www
.ajtmh.org .    
  Table  1 
    Serological results for clinically diagnosed dengue patients at the Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam  
    Single plasma samples were tested for dengue virus-reactive IgM by antigen-capture ELISA.   
Year
Total
Day of testing (since onset of illness)
≤ 4 days ≥ 5 days
Dengue patients Specimens tested Positive (%) Specimens tested Positive (%) Specimens tested Positive (%)
2004 3,791 419 73.0 58 65.5 361 74.2
2005 2,816 655 75.4 38 65.8 617 76.0
2006 5,147 1,540 63.8 112 27.7 1,428 66.6
2007 6,754 2,769 72.3 116 35.3 2,653 74.0
2008 10,811 4,012 75.5 168 41.7 3,844 77.0
2009 10,172 2,342 68.5 150 34.7 2,192 70.8
  Figure   3.        Male to female ratio of dengue patients and total hospi-
tal admissions. Points indicate the male to female ratio each year for 
(  A  ) total dengue admissions, (  B  ) cases of dengue shock syndrome, and 
(  C  ) all-cause admissions by hospital: Children’s Hospital Number 1 
(CH1; circles), Children’s Hospital Number 2 (CH2; squares), and 
Hospital for Tropical Diseases (HTD; triangles). The dashed line indi-
cates an equal ratio of males and females. This figure appears in color 
at   www.ajtmh.org .    130 ANDERS AND OTHERS
DSS cases between 1996 and 2009 were children. Overall, 
14.3% of children with a clinical diagnosis of dengue at the 
three hospitals had DSS (annual range = 9.2–28.5%) compared 
with 1.6% (annual range = 0.6–6.7%) of adult dengue cases. 
No trend was observed in the proportion of dengue cases 
manifesting as DSS over time (  Figure 4A  ). 
    The overall case fatality rate (CFR) within the study pop-
ulation between 1996 and 2009 was 0.25% (325 of 132,480). 
Annual case fatality rates ranged from 0.10% in 2004 to 0.64% 
in 1996, with a clear decreasing trend over time (  Figure 4B  ) 
(average change in CFR per year = −0.04%, 95% CI = −0.06% 
to −0.02%). As expected, the majority of deaths occurred in 
patients with DSS: the CFR among DSS patients was 1.6% 
(153/9,784) compared with 0.03% (28/92,683) among clinically 
diagnosed dengue patients that did not have DSS. 
  Overall, mortality was higher in children than in adult den-
gue patients (CFR 0.20% versus 0.11%;   P   = 0.002), but among 
those adults with DSS (  N   = 484), mortality was much higher 
than in pediatric DSS patients (CFR 5.5% versus 1.4%;   P   < 
0.001). 
      Demographic risk factors for DSS.    A  better  understanding 
of risk factors for DSS is important for understanding its 
pathogenesis and for the introduction of new prevention 
strategies, such as vaccines. To this end, we analyzed the 
available demographic characteristics of the 75,057 pediatric 
dengue patients admitted to CH1 and CH2 between 2000 
and 2009 and to HTD between 2001 and 2009. Sex, age group, 
hospital, location of residence (HCMC or province), year, and 
season of admission (dry or wet) were all associated with DSS 
by univariate analysis (  P   < 0.001). In a multivariate logistic 
regression model (  Table 2  ), with the exception of season 
of admission, each of these variables was independently 
associated with DSS after adjusting for the model covariates. 
The risk of DSS had a non-linear relationship with age, with 
shock more prevalent among pediatric dengue patients aged 
6–10 years than younger age groups or older children. A greater 
proportion of girls than boys had DSS; however, males still 
represented the majority of pediatric DSS patients because of 
their overall predominance in case numbers (  Table 2  ). 
        Risk  factors  for  mortality.     Univariate and multivariate 
analyses of variables associated with mortality were performed 
first with a denominator of dengue patients of all severities 
(  Table 3  ) and then within DSS patients only (  Table 4  ). The 
multivariate models were fitted with the same covariates as 
the DSS model: sex, age group, hospital, location of residence, 
year, and season of admission. With the exception of season of 
admission, all of these variables were significantly associated 
with mortality by univariate analysis (  P   < 0.001). Although 
girls were underrepresented among DSS patients, they had a 
significantly higher mortality than boys, both as a proportion 
of all dengue cases (adjusted odds ratio [AOR] = 1.57, 95% 
CI = 1.14–2.17) and among DSS cases (AOR = 1.51, 95% 
CI = 1.06–2.15). Although children over the age of 5 years 
were more likely to have DSS, younger children had poorer 
outcomes. Both total mortality and mortality associated with 
DSS peaked in children aged 1–5 years and declined with age 
(6–10 years AOR = 0.40, 95% CI = 0.27–0.59 and 11–15 years 
AOR = 0.28, 95% CI = 0.16–0.48 compared with 1–5 years 
AOR and CI). Indeed, it is striking that the risk of death is 
approximately four times higher in a child aged 1–5 years than 
a child aged 11–15 years. The odds of mortality were two times 
as high among DSS patients resident outside Ho Chi Minh 
City compared with city residents (AOR = 2.10, 95% CI = 
1.43–3.10) and among DSS patients at CH1 compared with 
HTD (AOR = 1.94, 95% CI = 1.04–3.61) or CH2. 
             Minimum  incidence  of  dengue  in  HCMC  in  2008–2009.  
  Using the dengue case burden documented at the three 
hospitals and district-level population data for HCMC as a 
denominator, we calculated a minimum estimate of the annual 
incidence of dengue requiring hospitalization in 2008 and 2009. 
In HCMC as a whole, 251 per 100,000 people in 2008 and 199 
per 100,000 people in 2009 were admitted to one of the three 
study hospitals with a clinical diagnosis of dengue. We also 
estimated the minimum incidence in children aged 15 years 
and under. In 2008, 712 children per 100,000 in HCMC were 
hospitalized with suspected dengue, and remarkably, in four 
districts, this exceeded 1,000 per 100,000 or 1% of children. 
In 2009, at least 518 per 100,000 children in HCMC were 
hospitalized with suspected dengue. Because this estimate 
includes a proportion of patients who may not have had a true 
dengue virus infection, we also calculated a minimum estimate 
of the annual incidence of DSS in children in HCMC by district 
of residence, because the clinical diagnosis for DSS has much 
higher specificity than for non-shock dengue. In 2008, 74 per 
100,000 children resident in HCMC were admitted to one of 
the three study hospitals with DSS, and the incidence of DSS 
in individual HCMC districts ranged from 7 to 152 per 100,000 
  Figure   4.        Disease severity and mortality among dengue patients. 
(  A  ) Bars show the number of dengue patients admitted to the three 
study hospitals each year from 1996 to 2009 by disease severity. Red 
bars show pediatric DF/DHF (striped) and DSS (solid) cases. White 
and blue bars show adult DF/DHF (white) and DSS (blue) cases. Note 
that 1996 to 1999 excludes data from Children’s Hospital Number 2, 
because figures on disease severity were not available. (  B  ) Lines show 
the case fatality rate among all pediatric (≤ 15 years; solid line) and 
adult (> 15 years; dotted line) dengue patients admitted to the three 
study hospitals each year from 1996 to 2009. This figure appears in 
color  at   www.ajtmh.org .    131 DENGUE IN VIETNAM
children (  Figure 5A  ). In 2009, the minimum estimate for DSS 
incidence was 57 per 100,000 children for HCMC as a whole 
and ranged from 15 to 127 per 100,000 children in individual 
districts of HCMC (  Figure 5B  ). 
     DISCUSSION 
  This retrospective study of more than 100,000 patients 
describes the epidemiological profile of dengue cases admit-
ted to three large hospitals in Ho Chi Minh City, Vietnam, 
between 1996 and 2009. Against a backdrop of surging inci-
dence and oscillations in virus serotype, we show that girls and 
very young children hospitalized with a clinical diagnosis of 
dengue are at the highest risk of a poor outcome, and this has 
implications for implementation of vaccines and therapeutics. 
  A steep increase in the adult and pediatric dengue case 
burden is apparent at each of the study hospitals in HCMC 
over the last decade. The majority of the combined dengue 
  Table  2 
    Prevalence of dengue shock syndrome among hospitalized pediatric dengue patients   
Variable   N   total  N 
Dengue shock syndrome
Percent OR 95% CI AOR 95% CI
Total 75,057 9,392 12.51
Sex
Male 43,519 5128 11.78 1.0 1.0
Female 31,538 4264 13.52 1.17 *  1.12–1.22 *  1.19 *  1.14–1.24 * 
Age group
<  1 3,318 281 8.47 0.68 *  0.60–0.78 *  0.62 *  0.54–0.71 * 
1–5 16,315 1,944 11.92 1.0 1.0
6–10 27,499 4,262 15.50 1.36 *  1.28–1.44 *  1.40 *  1.32–1.49 * 
11–15 27,925 2,905 10.40 0.86 *  0.81–0.91 *  0.95 0.89–1.03
Hospital
HTD 18,980 1,773 9.34 1.0 1.0
CH1 33,542 5,515 16.44 1.91 *  1.80–2.02 *  1.79 *  1.69–1.90 * 
CH2 22,535 2,104 9.34 1.0 0.94–1.07 0.96 0.89–1.03
Residence † 
HCMC 53,070 5,608 10.57 1.0 1.0
Province 20,340 3,677 18.08 1.87 *  1.79–1.95 *  1.79 *  1.69–1.90 * 
Season ‡ 
Dry 19,549 2,612 13.36 1.0 1.0
Wet 55,508 6,780 12.21 0.90 *  0.86–0.95 *  0.96 0.91–1.0
    HTD = Hospital for Tropical Disease; CH1 = Children’s Hospital Number 1; CH2 = Children’s Hospital Number 2; HCMC = Ho Chi Minh City; OR = odds ratio; AOR = adjusted odds ratio 
(adjusted for sex, age group, hospital, location of admission, year, and season of admission).   
  *   Values  are  significant  at   P   < 0.001.   
    †     Location of residence was missing for 1,651 patients and imputed for multivariate analysis.   
    ‡     Dry season is January to June, and wet season is July to December.   
  Table  3 
    Mortality among hospitalized pediatric dengue patients   
Variable   N   total
Mortality among all dengue cases
  N  Percent OR 95% CI AOR 95% CI
Total 75,057 150 0.20
Sex
Male 43,519 70 0.16 1.0 1.0
Female 31,538 80 0.25 1.58 *  1.14–2.18 *  1.57 *  1.14–2.17 * 
Age group
< 1 3,318 11 0.33 0.84 0.44–1.60 0.73 0.38–1.38
1–5 16,315 64 0.39 1.0 1.0
6–10 27,499 53 0.19 0.49 *  0.34–0.71 *  0.52 *  0.36–0.75 * 
11–15 27,925 22 0.08 0.20 *  0.12–0.33 *  0.27 *  0.16–0.44 * 
Hospital
HTD 18,980 13 0.07 1.0 1.0
CH1 33,542 121 0.36 5.28 *  2.98–9.36 *  3.60 *  2.00–6.49 * 
CH2 22,535 16 0.07 1.04 0.50–2.15 0.87 0.41–1.85
Residence † 
HCMC 53,070 48 0.09 1.0 1.0
Province 20,340 102 0.50 5.57 *  3.95–7.85 *  3.98 *  2.80–5.66 * 
Season ‡ 
Dry 19,549 50 0.26 1.0 1.0
Wet 55,508 100 0.18 0.70 §  0.50–0.99 0.88 0.62–1.24
    HTD = Hospital for Tropical Disease; CH1 = Children’s Hospital Number 1; CH2 = Children’s Hospital Number 2; HCMC = Ho Chi Minh City; OR = odds ratio; AOR = adjusted odds ratio 
(adjusted for sex, age group, hospital, location of admission, year, and season of admission).   
  *   Values  are  significant  at   P   < 0.001.   
    †     Location of residence was missing for 1,651 patients and imputed for multivariate analysis.   
    ‡     Dry season is January to June, and wet season is July to December.   
  §   Value  significant  at   P   = 0.05.   132 ANDERS AND OTHERS
burden at the three hospitals remains in children under the 
age of 15 years; however, adults now represent an increas-
ing majority of the caseload at HTD. The median age of adult 
cases at HTD increased steadily from 20 to 23 years between 
2001 and 2009. Although this observation is from one hospital 
and may not be a general trend, to our knowledge, there has 
not been any change in referral policy or care-seeking behav-
ior that alone explains such a substantial increase in the adult 
dengue patient population at this hospital. It is possible that 
this reflects migration in adulthood from non- or less-endemic 
areas of Vietnam to this high transmission setting, where 
adults are disproportionally more likely to be symptomatic on 
infection.  7,  12   In Thailand, a substantial increase in the average 
age of dengue cases has occurred over the past 20 years, and 
this has been attributed to demographic changes, leading to an 
aging population and a reduced force of infection.  7   However, 
the absence of any sustained increase in the median age of 
Vietnamese pediatric cases and the increase in population-
based incidence estimated from surveillance data suggest that 
the falling dengue transmission intensity reported in Thailand 
is not currently replicated in southern Vietnam. 
  Our dataset represents patients admitted to hospitals with 
a clinical diagnosis of dengue recorded at discharge. Clinically 
diagnosed dengue is not routinely laboratory confirmed in 
  Table  4 
    Mortality among pediatric patients with dengue shock syndrome   
Variable   N   DSS
Mortality among DSS cases
  N  Percent OR 95% CI AOR 95% CI
Total 9,392 131 1.39
Sex
Male 5,128 56 1.09 1.0 1.0
Female 4,264 75 1.76 1.62 *  1.14–2.30 *  1.51 *  1.06–2.15 * 
Age group
< 1 281 8 2.85 0.95 0.45–2.02 1.03 0.48–2.20
1–5 1,944 58 2.98 1.0 1.0
6–10 4,262 46 1.08 0.35 *  0.24–0.52 *  0.40 *  0.27–0.59 * 
11–15 2,905 19 0.65 0.21 *  0.13–0.36 *  0.28 *  0.16–0.48 * 
Hospital
HTD 1,773 12 0.68 1.0 1.0
CH1 5,515 104 1.89 2.82 *  1.55–5.14 *  1.94 *  1.04–3.61 * 
CH2 2,104 15 0.71 1.05 0.49–2.26 0.87 0.40–1.90
Residence † 
HCMC 5,608 43 0.77 1.0 1.0
Province 3,677 88 2.39 3.17 *  2.20–4.58 *  2.10 *  1.43–3.10 * 
Season ‡ 
Dry 2,612 47 1.80 1.0 1.0
Wet 6,780 84 1.24 0.68 §  0.48–0.98 0.80 0.55–1.15
    HTD = Hospital for Tropical Disease; CH1 = Children’s Hospital Number 1; CH2 = Children’s Hospital   
    Number 2; HCMC = Ho Chi Minh City; OR = odds ratio; AOR = adjusted odds ratio (adjusted for sex, age group, hospital, location of admission, year, and season of admission).   
  *   Values  are  significant  at   P   < 0.001.   
    †     Location of residence was missing for 1,651 patients and imputed for multivariate analysis.   
    ‡     Dry season is January to June, and wet season is July to December.   
  §   Value  is  significant  at   P   = 0.04.   
  Figure   5.        District-level minimum incidence of dengue shock syndrome in HCMC. Maps showing the estimated minimum incidence of 
DSS per 100,000 children in each district of HCMC in (  A  ) 2008 and (  B  ) 2009 based on DSS cases hospitalized at one of the three study hos-
pitals and district-level population data. The locations of the three study hospitals are also shown: Hospital for Tropical Diseases (HTD ★), 
Children’s Hospital Number 1 (CH1 ■), and Children’s Hospital Number 2 (CH2 ▲). This figure appears in color at   www.ajtmh.org  .       133 DENGUE IN VIETNAM
Vietnam or in many other endemic countries, and a clinical 
dengue diagnosis is the basis for routine reporting to national 
surveillance systems here as elsewhere. We accept that a pro-
portion of the cases included in our analysis will not be true 
dengue cases, and we attempt to quantify this proportion using 
laboratory data from HTD, which shows that more than 70% 
of the clinically diagnosed dengue cases tested have detectable 
DENV-specific IgM indicative of an acute or very recent infec-
tion. Therefore, it is plausible that some of the patient charac-
teristics that we identified as being associated with a diagnosis 
of DSS or overall mortality could be confounded by the imper-
fect accuracy of the clinical diagnosis. In contrast, the accuracy 
of a clinical diagnosis of DSS is extremely high: among 2,628 
clinically diagnosed DSS patients enrolled in ongoing research 
studies at HTD (1999–2009), CH1, and CH2 (2008–2009), 98% 
were subsequently laboratory confirmed as dengue cases (Wills 
B and Simmons CP, unpublished data). Therefore, our results 
derived from the DSS patient population (  N   = 9,392 cases) are 
highly unlikely to be confounded by misdiagnosed cases. 
  DSS is primarily a complication of dengue in children, and 
we found no evidence to suggest that the increase in case 
prevalence among adults at HTD was associated with a par-
allel increase in the prevalence of DSS among this age group. 
When DSS did manifest in adults, it was associated with a 
higher mortality rate than in children with DSS. A review 
of fatal adult dengue cases at HTD found that almost all of 
these patients developed DSS before admission to HTD, usu-
ally on or after day 6 of illness, and often had been referred 
from a district or provincial hospital (Chau NVV, personal 
communication). Thus, higher mortality rates in adults with 
DSS likely reflect patient referral patterns and not necessarily 
true CFRs. Mortality within the study population was low and 
decreased substantially throughout the 14-year study period. 
The vast majority of fatal cases occurred in patients with 
shock, although the CFR within shock patients also decreased 
over time. We found that the age and sex of pediatric dengue 
patients were strongly associated with the risk of both DSS 
and mortality. Although both the prevalence and frequency of 
DSS was highest in children aged 6–10 years, younger children 
aged 1–5 years were at significantly higher risk of mortality 
than older children. This is consistent with population-based 
reports of age-specific morbidity and mortality in second-
ary DENV-2 infections (after DENV-1) occurring in an out-
break situation.  13   However, to our knowledge, this is the first 
report to provide precise estimates of the age-specific relative 
risk of mortality among a large hospitalized pediatric den-
gue patient population. Knowledge of the age-specific risk of 
dengue is critical for rational implementation of dengue vac-
cines and anti-viral drugs. The substantial burden of severe 
disease and the increased risk of mortality in the youngest 
children support the delivery of dengue vaccines and poten-
tially in the future, dengue anti-viral drugs to pre-school–aged 
children to achieve greatest impact on disease burden and 
mortality. 
  A substantial and unexpected bias to males was observed 
among dengue cases. This could not be explained by popu-
lation demographics, because in urban Vietnam, the average 
male:female ratio in children is around 108:100 and in adults, is 
skewed to females.  14  A biological basis for increased innate sus-
ceptibility to dengue in males is possible, but this has not been 
documented and is not evidenced in a number of smaller hos-
pital-based studies that have variously reported no difference, 
a male excess, or a female excess in dengue patient popula-
tions.  15–  19   Differential exposure between males and females is 
a possible but unlikely cause of this gender distribution, espe-
cially in children. Healthcare-seeking behavior might account 
for the gender bias observed not only for dengue but also for 
total admissions at the pediatric hospitals, which saw more than 
two times as many boys as girls admitted in some years. The 
bias to males was particularly marked in 2003–2006; however, 
we are not aware of any changes in hospital policies or public 
health activities during this time that might explain a gender-
specific change in healthcare-seeking behavior. Others have 
reported a gender disparity of similar magnitude among pedi-
atric hospital admissions for all causes in Hong Kong,  20   but the 
relative contribution of innate susceptibility and healthcare-
seeking behavior remains unclear. Qualitative studies are war-
ranted to further investigate factors influencing care-seeking 
behavior and triage decisions and the effect of these behav-
iors on access to healthcare and health outcomes for girls and 
women. 
  Interestingly, although girls were underrepresented among 
dengue patients of all severities, they experienced higher mor-
tality than boys. A preponderance of females among severe 
dengue cases but not mild cases has been reported previously 
in two small studies  21,  22   and was suggested to reflect either a 
more robust cellular immune response or a higher intrinsic 
susceptibility to capillary permeability in females than males.  5  
The fact that a substantially higher mortality rate in females 
persists even within DSS cases alone suggests that there is a 
biological component to this gender-associated risk, although 
this could still be influenced by behavioral factors such as time 
of presentation or differences in the type of care provided to 
girls and boys. 
 Residence outside HCMC and admission to CH1 (compared 
with either HTD or CH2) were independently associated with 
a significantly higher prevalence of both DSS and mortality 
among our pediatric study population. This association prob-
ably reflects, in part, the different case mix of the hospitals and 
the referral patterns within HCMC and from the provinces. 
DSS patients that reside outside of HCMC may well have 
been referred late in their illness and with more severe disease. 
Although the data were not available to investigate this pos-
sibility, it highlights the pressing need for early diagnostics and 
prognostic markers of progression to severe disease so that 
appropriate monitoring, supportive treatment, and referral, if 
necessary, can be delivered in the earlier stage of illness. 
  In 2008, at least 1 in every 140 children in Ho Chi Minh City 
was admitted to one of the three study hospitals with a clini-
cal diagnosis of dengue. This startlingly high disease burden 
underscores the failure of existing vector control strategies 
and the urgent need for vaccines. We observed a wide range in 
the district-level estimates of DSS incidence in children. Given 
the high specificity of a clinical diagnosis of DSS and the fact 
that the vast majority of DSS cases in HCMC are likely to 
be admitted to one of the three tertiary hospitals included 
in this study, either directly or by referral, this represents a 
reasonable estimate of the population incidence and distri-
bution of DSS in HCMC. Assuming a constant extrapolation 
factor from DSS cases to total dengue cases and infections, 
this picture suggests a heterogeneous distribution of dengue 
risk in HCMC. A better understanding of the spatial distri-
bution of dengue risk through population-based studies could 
help to inform vector control activities that are constrained by 134 ANDERS AND OTHERS
limited resources and may provide insight into some of the 
demographic and environmental determinants of the increas-
ing case burden. 
  The rational implementation of dengue vaccines and treat-
ment interventions can be guided by detailed clinical and 
epidemiological data such as described here. Although hospital-
based data suffer several limitations, including a bias to more 
severe disease, the severe end of the disease spectrum is where 
the biggest health impact will be made by both vaccines and 
therapeutics. 
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